NYSE
INSP

Inspire Medical Systems Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Inspire Medical Systems Inc Stock Price

Vitals

Today's Low:
$215.685
Today's High:
$223.2
Open Price:
$222.6
52W Low:
$159.615
52W High:
$330
Prev. Close:
$223.54
Volume:
748340

Company Statistics

Market Cap.:
$7.01 billion
Book Value:
18.051
Revenue TTM:
$526.08 million
Operating Margin TTM:
-10.19%
Gross Profit TTM:
$341.74 million
Profit Margin:
-7.81%
Return on Assets TTM:
-7.36%
Return on Equity TTM:
-10.86%

Company Profile

Inspire Medical Systems Inc had its IPO on 2018-05-03 under the ticker symbol INSP.

The company operates in the Healthcare sector and Medical Devices industry. Inspire Medical Systems Inc has a staff strength of 755 employees.

Stock update

Shares of Inspire Medical Systems Inc opened at $222.6 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $215.69 - $223.2, and closed at $219.51.

This is a -1.8% slip from the previous day's closing price.

A total volume of 748,340 shares were traded at the close of the day’s session.

In the last one week, shares of Inspire Medical Systems Inc have slipped by -8.1%.

Inspire Medical Systems Inc's Key Ratios

Inspire Medical Systems Inc has a market cap of $7.01 billion, indicating a price to book ratio of 15.7223 and a price to sales ratio of 21.2052.

In the last 12-months Inspire Medical Systems Inc’s revenue was $526.08 million with a gross profit of $341.74 million and an EBITDA of $-51292000. The EBITDA ratio measures Inspire Medical Systems Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Inspire Medical Systems Inc’s operating margin was -10.19% while its return on assets stood at -7.36% with a return of equity of -10.86%.

In Q2, Inspire Medical Systems Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 65.3%.

Inspire Medical Systems Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-1.41 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Inspire Medical Systems Inc’s profitability.

Inspire Medical Systems Inc stock is trading at a EV to sales ratio of 20.0207 and a EV to EBITDA ratio of -151.3975. Its price to sales ratio in the trailing 12-months stood at 21.2052.

Inspire Medical Systems Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$618.25 million
Total Liabilities
$66.69 million
Operating Cash Flow
$4.90 million
Capital Expenditure
$4.86 million
Dividend Payout Ratio
0%

Inspire Medical Systems Inc ended 2024 with $618.25 million in total assets and $0 in total liabilities. Its intangible assets were valued at $618.25 million while shareholder equity stood at $529.36 million.

Inspire Medical Systems Inc ended 2024 with $0 in deferred long-term liabilities, $66.69 million in other current liabilities, 29000.00 in common stock, $-351646000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $467.05 million and cash and short-term investments were $467.05 million. The company’s total short-term debt was $1,315,000 while long-term debt stood at $0.

Inspire Medical Systems Inc’s total current assets stands at $560.08 million while long-term investments were $0 and short-term investments were $0.00. Its net receivables were $63.50 million compared to accounts payable of $39.96 million and inventory worth $20.84 million.

In 2024, Inspire Medical Systems Inc's operating cash flow was $4.90 million while its capital expenditure stood at $4.86 million.

Comparatively, Inspire Medical Systems Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$219.51
52-Week High
$330
52-Week Low
$159.615
Analyst Target Price
$332

Inspire Medical Systems Inc stock is currently trading at $219.51 per share. It touched a 52-week high of $330 and a 52-week low of $330. Analysts tracking the stock have a 12-month average target price of $332.

Its 50-day moving average was $265.8 and 200-day moving average was $265.1 The short ratio stood at 2.09 indicating a short percent outstanding of 0%.

Around 156.8% of the company’s stock are held by insiders while 9986.9% are held by institutions.

Frequently Asked Questions About Inspire Medical Systems Inc

The stock symbol (also called stock or share ticker) of Inspire Medical Systems Inc is INSP

The IPO of Inspire Medical Systems Inc took place on 2018-05-03

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
ClearOne Inc (CLRO)
$0.78
0
+0.51%
$638.55
-36.55
-5.41%
$31.24
0.55
+1.79%
$40.24
-0.93
-2.26%
$1397.6
-20.65
-1.46%
$7.65
-0.23
-2.92%
$78.04
-0.16
-0.2%
$18.36
-0.32
-1.71%
$140.45
-1.3
-0.92%
$0
0
0%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Address

5500 Wayzata Boulevard, Golden Valley, MN, United States, 55416